Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2056.00 | 1754.88 | 1.1716 | 1.2472 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 1250.00 | 684.27 | 1559.00 | 1754.88 | 0.8884 | 0.8332 |
| BT-20 | Lapatinib | 10 | uM | 9 | 1250.00 | 684.27 | 528.00 | 1754.88 | 0.3009 | -0.1737 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1814.00 | 1754.88 | 1.0337 | 1.0494 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1862.00 | 1754.88 | 1.0610 | 1.0891 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1749.00 | 1754.88 | 0.9967 | 0.9951 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 684.27 | 490.00 | 1754.88 | 0.2792 | -0.2179 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1729.50 | 1754.88 | 0.9855 | 0.9787 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3666.00 | 3816.00 | 0.9607 | 0.9440 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4004.00 | 3816.00 | 1.0493 | 1.0693 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3642.00 | 3816.00 | 0.9544 | 0.9349 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1434.95 | 3806.00 | 3816.00 | 0.9974 | 0.9963 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1434.95 | 4084.00 | 3816.00 | 1.0702 | 1.0986 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3624.00 | 3816.00 | 0.9497 | 0.9282 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 1903.00 | 3816.00 | 0.4987 | 0.2215 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4080.00 | 3816.00 | 1.0692 | 1.0971 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1434.95 | 4247.00 | 3816.00 | 1.1129 | 1.1576 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4279.00 | 3816.00 | 1.1213 | 1.1691 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1434.95 | 1103.00 | 3816.00 | 0.2891 | -0.1701 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4007.00 | 3816.00 | 1.0501 | 1.0704 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3792.00 | 3816.00 | 0.9937 | 0.9911 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4161.00 | 3816.00 | 1.0904 | 1.1265 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4095.00 | 3816.00 | 1.0731 | 1.1026 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4256.00 | 3816.00 | 1.1153 | 1.1608 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3845.00 | 3816.00 | 1.0076 | 1.0108 |